The Latest Breaking News from Health Care

In February, the world’s richest man, Elon Musk, wielded a chainsaw at a conservative gathering as he gleefully spoke of his new role as head of the Department of Government Efficiency (DOGE), where he’ll soon reach his legal term limit. The chainsaw metaphor is brutally apt as he slashes government…

Since the mid-2000s, the Medicare system has dramatically transformed. Enrollment in Medicare Advantage – the private alternative to the traditional Medicare program administered by the government – has more than quadrupled. It now accounts for the majority of Medicare enrollment.

A community-led partnership in Colorado designed to negotiate health care prices lowered health care premiums in 2020 and 2021, we find in our new paper in the Journal of Risk and Insurance. The nonprofit organization is called the Peak Health Alliance.

Having the freedom to choose your own health care provider is something many Americans take for granted. But the Supreme Court is weighing whether people who rely on Medicaid for their health insurance have that right, and if they do – is it enforceable by law?

At different intervals, dueling speakers, a woman with a siren horn, a tuba band, a Christian rock band and more vied for attention.

Exclusive: Former staff tell Guardian Australia some HIV patients have since required acute mental health care, as hospital also loses specialist pain and eating disorder psychiatry services

US Attorney General Pam Bondi on Tuesday asked federal prosecutors to seek the death penalty for Luigi Mangione, who allegedly gunned down an American health care CEO in a brazen attack.

Supreme Court will hear arguments in a South Carolina case over whether states can cut off Medicaid funding to Planned Parenthood

As Charles River Laboratories has underperformed its industry peers recently, analysts remain cautious about the stock’s prospects.

Incyte has outperformed the health care sector over the past year, and analysts are moderately optimistic about the stock’s prospects.

DaVita has underperformed the health care services industry this year, and analysts are cautious about the stock’s prospects.